Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
207,440,936
-
Total 13F shares
-
24,622,739
-
Share change
-
-3,731,092
-
Total reported value
-
$296,764,346
-
Put/Call ratio
-
176%
-
Price per share
-
$12.05
-
Number of holders
-
135
-
Value change
-
-$61,226,730
-
Number of buys
-
55
-
Number of sells
-
60
Institutional Holders of Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) as of Q3 2021
As of 30 Sep 2021 Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) had 135 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 24,622,739 shares of stock of the company.
Largest 10 holders included Bellevue Group AG, WASATCH ADVISORS INC, Meditor Group Ltd, BlackRock Inc., VANGUARD GROUP INC, PLATINUM INVESTMENT MANAGEMENT LTD, Rhenman & Partners Asset Management AB, STATE STREET CORP, MARSHALL WACE, LLP, and MILLENNIUM MANAGEMENT LLC.
This table shows 137 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.